白细胞介素2激活脐血单个核细胞体外抗肿瘤活性的实验研究

为探讨白细胞介素２（ＩＬ－２）激活脐血单个核细胞（ＡＣＢ）对白血病细胞株ＨＬ－６０和Ｋ５６２细胞的杀伤作用以及脐血被激活后能否保持其造血祖细胞生成活性（ＰＣＡ），采用３Ｈ－胸腺嘧啶核苷前标记释放法和半固体培养等方法对其进行了研究。结果：ＩＬ－２激活的脐血细胞具有明显的抗肿瘤活性，且不影响其ＰＣＡ。ＩＬ－２激活脐血细胞的最适条件为：（１）细胞浓度为１×１０６ｍｌ；（２）ＩＬ－２浓度为１０００Ｕ／ｍｌ；（３）效靶比为１００１；（４）体外培养７２小时。脐血经ＩＬ－２激活后免疫表型发生明显变化，产生肿瘤坏死因子（ＴＮＦα）及白细胞介素６（ＩＬ－６），且生成大颗粒淋巴细胞（ＬＧＬ）。ＬＧＬ与Ｋ５６２细胞作用后，后者呈凋亡特征。研究结果为临床应用ＡＣＢ治疗白血病提供了实验依据。     

Diagnostic and Perinatal Management of Fetal Extrasystole

Fifty fetuses referred to the Polish Mother's Memorial Hospital for fetal echocardiography between January 1, 1991 and June 1, 1995 were evaluated. The mean fetal gestational age at the time of diagnosis of arrhythmia was 34.1 weeks, and the mean gestational age at the time of delivery was 38.7 weeks. Checkup echocardiographic examinations were performed every 10–14 days, for a mean 2.4 studies per fetus. In most cases (48/50, 96%), premature atrial contractions were present during the first echocardiography examination. The fetal heart study was normal in 30 cases; in 7 (14%) there was tricuspid valve regurgitation, in 7 (14%) an atrial septal aneurysm, in 4 congenital heart defects, in 1 myocardial hypertrophy, and in 1 disproportion in the four-chamber view. Of the 50 fetuses, 43 underwent regular echocardiographic monitoring alone; in 7 cases, based on the presence of additional echocardiographic findings, pharmacotherapy was applied (digoxin, verapamil, or both). Three neonates died after delivery owing to malformations in two cases (one critical aortic stenosis, one spina bifida plus hygroma colli) and due to myocarditis in one case. In six of seven newborns treated in utero, myocarditis was diagnosed after birth (including the one with neonatal demise). Most of the newborns were in good condition after birth, their mean Apgar score being 8.6 and the mean birth weight 3259 g. We concluded that most extrasystoles represent an isolated anomaly, not affecting the fetal condition. Their presence should not influence the obstetric care and may require only echocardiographic monitoring. In most of our cases the premature contractions subsided after birth, although sometimes they preceded fetal supraventricular tachycardia or appeared after congenital myocarditis.     

A randomized controlled trial of a new fetal acoustic stimulation test for fetal well-being

OBJECTIVES: Our purpose was to determine (1) whether a fetal acoustic stimulation test results in more palpable fetal movement compared with a mock test (control) and (2) whether palpated fetal movements after a fetal acoustic stimulation test are accompanied by a reactive nonstress test.STUDY DESIGN: In a randomized controlled trial we studied women seen in the labor and delivery suite for various indications. Women were excluded for multiple gestation, <31 weeks' gestational age, treatment with magnesium sulfate or narcotics, or ruptured membranes. Informed consent was obtained from eligible women, who were then randomized to a test or control group. We placed an acoustic stimulator on the abdomen of each woman, but only the test group was stimulated. We assessed fetal movement by a grading system: 0 = no fetal movement felt by patient or tester, 1 = fetal movement felt by patient only, 2 = fetal movement felt by tester, 3 = visual movement seen by tester. A positive fetal acoustic stimulation test result was defined as one with any fetal movement felt or seen by the tester (grades 2 or 3). We then performed a nonstress test. We compared rates of a positive fetal acoustic stimulation test in the test and control groups with the χ² test. A p value <0.05 was considered significant.RESULTS: We randomized 297 women to the test group and 280 women to the control (mock test) group. Of women tested with the fetal acoustic stimulation test, 81% had fetal movement by palpation or visualization (grades 2 or 3) compared with 19% of the control group (p < 0.0001, odds ratio 19.29, 95% confidence interval 12.42 to 30.07). Of the test group, 283 (95%) had a reactive nonstress test and 14 (5%) had nonreactive tests; the control group had 267 (95%) reactive and 13 (5%) nonreactive nonstress tests. Of 242 patients in the test group with a positive fetal acoustic stimulation test, 236 (98%) had a reactive nonstress test. Of those in the test group with fewer than three contractions per 10 minutes, 164 (89%) had a positive fetal acoustic stimulation test. Of these, 162 (99%) had a reactive nonstress test.CONCLUSION: The fetal acoustic stimulation test evokes significantly more palpated or visualized fetal movement than in controls. Palpated or visualized fetal movement after acoustic stimulation was almost always accompanied by a reactive nonstress test. (Am J Obstet Gynecol 1997;176:1386-8.)     

肿瘤坏死因子在妊高征发病中的作用

目的：探讨肿瘤坏死因子（ＴＮＦ）在妊高征发病中的作用及其对胎儿生长的影响。方法：应用放射免疫法对正常晚期妊娠妇女１６例（对照组）及妊高征患者４６例（妊高征组）的血浆、羊水和新生儿脐血中ＴＮＦ进行检测。结果：分娩前妊高征组血浆ＴＮＦ水平较对照组高，以中、重度妊高征者增高显著（Ｐ＜０．０５）；产后７２小时妊高征组血浆ＴＮＦ水平下降，与对照组差异无显著性。对照组及轻度妊高征者新生儿脐血ＴＮＦ水平与母血接近，羊水ＴＮＦ水平明显低于母血（Ｐ＜０．０５）；中、重度妊高征者脐血和羊水ＴＮＦ水平均较母血低（Ｐ＜０．０５；Ｐ＜０．０１）。新生儿脐血、羊水中ＴＮＦ水平在两组间差异无显著性。在中、重度妊高征者中，合并胎儿生长迟缓者其羊水和新生儿脐血ＴＮＦ水平明显高于未合并胎儿生长迟缓者。结论：ＴＮＦ可能作为母体对胎儿抗原的异常免疫反应的重要介质，在妊高征的发病中起一定作用。     

妊高征患者的胎儿血流速度波形改变特点研究

目的：研究妊高征患者的胎儿脐动脉、肾动脉以及大脑中动脉的血流速度波形的变化特点。方法：妊高征患者９６例，正常妊娠１４８例，于产前１周内行彩色多普勒超声检测胎儿脐动脉、肾动脉和大脑中动脉的搏动指数（ＰＩ），产后随访新生儿预后。结果：随着妊高征的加剧，胎儿脐动脉和肾动脉的ＰＩ上升，大脑中动脉的ＰＩ则改变不明显。在围产儿预后良好和不良的两组中，随着妊高征的加重，胎儿脐动脉、肾动脉和大脑中动脉的ＰＩ均有上升的趋势，但预后不良组的改变比对照组明显。按正常妊娠和轻度、中度、重度妊高征分成４组，胎儿窘迫者脐动脉和肾动脉的ＰＩ上升，大脑中动脉的ＰＩ下降。结论：妊高征和胎儿窘迫对胎儿脐动脉和肾动脉的血流波形改变有协同作用，对大脑中动脉的改变有阻抗作用     

碱性成纤维细胞生长因子对胎鼠宫内窘迫脑损害的疗效观察

目的探讨母鼠应用碱性成纤维细胞生长因子（ｂＦＧＦ）是否对胎鼠宫内窘迫脑损害有保护作用。方法将５３只胎龄为２０天的ＳＤ大鼠胎鼠随机分为五组，即正常对照组（Ｃ组）１１只，窘迫对照组（Ｅ组）１０只，ｂＦＧＦ治疗组Ⅰ（Ｄ１组）１０只，ｂＦＧＦ治疗Ⅱ组（Ｄ２组）１０只，ｂＦＧＦ治疗Ⅲ组（Ｄ３组）１２只。在不同时间内静脉注射ｂＦＧＦ，监测静脉注射ｂＦＧＦ后胎鼠脑细胞内外钙、钠、钾含量的变化。结果在钳夹血管前２０分钟静脉注射ｂＦＧＦ后胎鼠脑细胞胞游离钙离子浓度为４７５±９１ｎｍｏｌ／Ｌ；再灌注同时静脉注射ｂＦＧＦ后游离钙离子浓度为４７４±４９ｎｍｏｌ／Ｌ。表明ｂＦＧＦ干预组均明显高于正常对照组（３１５±８７ｎｍｏｌ／Ｌ）（Ｐ＜００１），但亦均低于窘迫对照组（５５２±９４ｎｍｏｌ／Ｌ）（Ｐ＜００５）；同时这两组的脑组织总钙、总钠及总钾含量亦有不同程度的下降。结论无论是在窘迫前还是在缺血再灌注同时静脉注射ｂＦＧＦ，ｂＦＧＦ均可减轻宫内窘迫胎鼠脑细胞钙超载，减轻脑水肿，保护缺氧脑细胞；提示对产妇或窒息新生儿应用ｂＦＧＦ可能有助于减轻窒息新生儿脑损伤     

新生儿窒息513例临床分析

目的 探讨新生儿窒息的相关因素及预防措施。方法 对1995年1月～2004年12月哈尔滨二四二医院住院分娩发生的新生儿窒息513例临床资料进行分析。结果 新生儿窒息与胎儿窘迫高度相关。脐带因素、产程异常、胎盘功能不全是新生儿窒息的主要产科原因。结论 新生儿窒息是胎儿窘迫产程中缺氧在出生后的表现和继续。应以预防为主：要重视产前检查，对高危妊娠进行系统管理，指导胎动计数，加强产程监护，综合判断后选择最佳分娩方式。一旦发生，及时进行复苏术。     

42例子痫对围产儿影响的分析

目的 :探讨子痫对围产儿的影响。方法 :回顾 8年间 4 2例子痫与早产、胎儿宫内窘迫、终止妊娠时机及新生儿窒息的关系 ,并分析子痫对围产儿的影响。结果 :4 2例子痫中早产、胎儿宫内窘迫、新生儿窒息的发生率较高。结论 :控制子痫的发生是提高围产儿质量重要措施之一     

实时荧光聚合酶链反应定量检测LASIK术后兔角膜纤维连接蛋白1的表达

目的　定量检测纤维连接蛋白 1(fibronectin 1,FN1)在LASIK术后不同时段角膜中的表达水平 ,探讨FN1与LASIK术后早期伤口愈合的关系。方法　 2 0只新西兰白兔 ,左眼按近视 4D行LASIK术 ,右眼作对照组。分别于术后 4、4 8h ,1、2周取角膜 ,荧光半定量PCR方法检测中央手术区及周边非手术区角膜FN1mRNA的表达。结果　LASIK术后 4h左眼手术区FN1的mRNA表达水平比右眼相应对照区明显升高 ,4 8h降低至对照组水平 ,其后随时间的延长无明显改变。结论　实时荧光定量PCR定量检测FN1在角膜中的表达结果提示 ,FN1参与LASIK术后角膜瓣与基质床的粘附过程     

孕妇血清HBV-DNA含量对预测胎儿宫内感染的临床价值

目的:探讨孕妇血清HBV-DNA含量对预测胎儿宫内感染的临床价值。方法:应用聚合酶链反应(PCR)法检 测103例乙型肝炎表面抗原(HBsAg)阳性孕妇的血清HBV-DNA含量,并对相关因素进行分析。结果:103例HBsAg阳性孕妇 的HBV-DNA检出阳性率为56%,胎儿宫内感染率为12.6％,且胎儿宫内感染率随血清HBV-DNA含量的增加而升高, HBV-DNA含量与胎儿宫内感染率呈正相关(r=0.572,P<0.01)。结论:孕妇血清HBV-DNA含量可间接预测胎儿宫内感染 的发生率。